Abstract | BACKGROUND: Low-dose photodynamic therapy PDT (photoinduction) can modulate tumor vessels and enhance the uptake of liposomal cisplatin (Lipoplatin®) in pleural malignancies. However, the photo-induction conditions must be tightly controlled as overtreatment shuts down tumor vessels and enhances normal tissue drug uptake. MATERIAL AND METHODS: In a pleural sarcoma and adenocarcinoma rat model (n = 12/group), we applied photoinduction (0.0625 mg/kg Visudyne®, 10 J/cm2 ) followed by intravenous Lipoplatin® (5 mg/kg) administration. Tumor and normal tissue IFP were assessed before and up to 1 hour following photoinduction. Lipoplatin® uptake was determined 60 minutes following photoinduction. We then treated the pleura of tumor-free minipigs with high dose photodynamic therapy ( PDT) (0.0625 mg/kg Visudyne®, 30 J/cm2 , n = 5) followed by Lipoplatin (5 mg/kg) administration. RESULTS: In rodents, photoinduction resulted in a significant decrease of IFP (P < 0.05) in both tumor types but not in the surrounding normal lung, equally exposed to light. Also, photoinduction resulted in a significant increase of Lipoplatin® uptake in both tumor types (P < 0.05) but not in normal lung. Tumor IFP variation and Lipoplatin® uptake fitted an inverted parabola. In minipigs, high dose photodynamic treatment resulted in pleural IFP increase of some animals which predicted higher Lipoplatin® uptake levels. CONCLUSION: Normal and tumor vasculatures react differently to PDT. Continuous IFP monitoring in normal and tumor tissues is a promising biomarker of vessel photoinduction. Moderate drop in tumor with no change in normal tissue IFP are predictive of specific Lipoplatin® uptake by cancer following PDT. Lasers Surg. Med. 49:773-780, 2017. © 2017 Wiley Periodicals, Inc.
|
Authors | Sabrina Cavin, Xingyu Wang, Matthieu Zellweger, Michel Gonzalez, Michaël Bensimon, Georges Wagnières, Thorsten Krueger, Hans-Beat Ris, Fabrizio Gronchi, Jean Y Perentes |
Journal | Lasers in surgery and medicine
(Lasers Surg Med)
Vol. 49
Issue 8
Pg. 773-780
(10 2017)
ISSN: 1096-9101 [Electronic] United States |
PMID | 28544068
(Publication Type: Journal Article)
|
Copyright | © 2017 Wiley Periodicals, Inc. |
Chemical References |
- Antineoplastic Agents
- Biomarkers
- Photosensitizing Agents
- Porphyrins
- lipoplatin
- Verteporfin
- Cisplatin
|
Topics |
- Adenocarcinoma
(drug therapy, metabolism)
- Animals
- Antineoplastic Agents
(pharmacokinetics, therapeutic use)
- Biomarkers
- Cell Line, Tumor
- Cisplatin
(pharmacokinetics, therapeutic use)
- Extracellular Fluid
(physiology)
- Injections, Intravenous
- Male
- Photochemotherapy
(methods)
- Photosensitizing Agents
(therapeutic use)
- Pleural Neoplasms
(drug therapy, metabolism)
- Porphyrins
(therapeutic use)
- Pressure
- Rats
- Rats, Inbred F344
- Sarcoma
(drug therapy, metabolism)
- Swine
- Verteporfin
|